Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Almgren, Malin ^a,b   Atkinson, Richard ^c   He, Jia ^c   Hilding, Agneta ^a   Hagman, Emilia ^a   Wolk, Alicja ^a   Thorell, Anders ^d   Marcus, Claude ^a   Näslund, Erik ^e   Östenson, Claes Göran ^a   Schalling, Martin ^a,b   Lavebratt, Catharina ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d ERSTA HOSPITAL   (Sweden)

^e DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ADENOVIRUS 36; ADENOVIRUS INFECTION; ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK FACTOR; SCHOOL CHILD; SEROLOGY; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS DETECTION;

ADENOVIRIDAE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; SWEDEN; TIME FACTORS;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS;

EID: 84864591398     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041652     Document Type: Article

References (41)

1. Wigand R, Gelderblom H, Wadell G,((1980)) New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol. 64:: 225--233.
2. Echavarria M,((2009)) Adenovirus. In: Zuckerman, A.J, Banatvala, J.E, Schoub, B.D, Griffiths, P.D, Mortimer, P (Eds), Principles, Practice of Clinical Virology, ed. John Wiley and Sons, San Diego, CA, 463-488.
3. Arnold J, Jánoska M, Kajon AE, Metzgar D, Hudson NR, et al.((2010)) Genomic characterization of human adenovirus 36, a putative obesity agent. Virus Res 149(2):: 152--161.
4. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, et al.((2000)) Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 24(8):: 989--996.
5. Dhurandhar NV, Whigham LD, Abbott DH, Schultz-Darken NJ, Israel BA, et al.((2002)) Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr. 2002 132(10):: 3155--3160.
6. Pasarica M, Shin AC, Yu M, Ou Yang HM, Rathod M, et al.((2006)) Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity 14(11):: 1905--1913.
7. Pasarica M, Loiler S, Dhurandhar NV,((2008)) Acute effect of infection by adipogenic human adenovirus Adv36. Arch Virol 153(11):: 2097--2102.
8. Pasarica M, Mashtalir N, McAllister EJ, Kilroy GE, Koska J, et al.((2008)) Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adiposederived stem cells. Stem Cells 26(4):: 969--978.
9. Rogers PM, Fusinski KA, Rathod MA, Loiler SA, Pasarica M, et al.((2008)) Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond). 32(3):: 397--406.
10. Dhurandhar NV, Kulkarni P, Ajinkya SM, Sherikar A,((1992)) Effect of adenovirus infection on adiposity in chicken. Vet Microbiol. 31(2-3):: 101--107.
11. Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, et al.((2007)) Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond). 2007 31(1):: 87--96.
12. Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV,((2004)) A human adenovirus enhances preadipocyte differentiation. Obes Res 12(5):: 770--777.
13. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, et al.((2005)) Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 29(3):: 281--286.
14. Na HN, Kim J, Lee HS, Shim KW, Kimm H, et al.((2011)) Association of human adenovirus-36 in overweight Korean adults. Int J Obes (Lond) May 17.
15. Trovato GM, Castro A, Tonzuso A Garozzo A, Martines GF, et al.((2009)) Human obesity relationship with Adv36 adenovirus and insulin resistance. Int J Obes 33:: 1402--1409.
16. Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, et al.((2010)) Adv36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 30(2):: 184--190.
17. Na HN, Hong YM, Kim J, Kim HK, Jo I, et al.((2010)) Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond) 34(1):: 89--93.
18. Gabbert C, Donohue M, Arnold J, Schwimmer JB,((2010)) Adenovirus 36 and obesity in children and adolescents.Pediatrics. 126(4):: 721--726.
19. Atkinson RL, Lee I, Shin HJ, He J,((2010)) Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes 5(2):: 157--160.
20. Wang ZQ, Cefalu WT, Zhang XH, Yu Y, Qin J, et al.((2008)) Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes 57(7):: 1805--1813.
21. Rogers PM, Mashtalir N, Rathod MA, Dubuisson O, Wang Z, et al.((2008)) Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes 57(9):: 2321--2331.
22. Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, et al.((2011)) Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 300(5):: E779--789.
23. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH,((2000)) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320(7244):: 1240--1243.
24. Rolland-Cachera MF, Sempé M, Guilloud-Bataille M, Patois E, Péquignot-Guggenbuhl F, et al.((1982)) Adiposity indices in children. Am J Clin Nutr 36:: 178--184.
25. Morinder G, Larsson UE, Norgren S, Marcus C,((2009)) Insulin sensitivity, VO2max and body composition in severely obese Swedish children and adolescents. Acta Paediatr 98(1):: 132--138.
26. Alberti KG, Zimmet PZ,((1998)) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of WHO consultation. Diabetic Med 15:: 539--553.
27. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ,((1965)) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:: 1375--1384.
28. Neovius M, Teixeira-Pinto A, Rasmussen F,((2008)) Shift in the composition of obesity in young adult men in Sweden over a third of a century. Int J Obes (Lond) 32(5):: 832--836.
29. Goossens VJ, Dejager SA, Grauls GE, Gielen M, Vlietinck RF, et al.((2011)) Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring) 19(1):: 220--221.
30. Broderick MP, Hansen CJ, Irvine M, Metzgar D, Campbell K, et al.((2010)) Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes (Lond) 34(2):: 302--308.
31. Goodwin K, Viboud, Simonsen L,((2006)) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24:: 1159--1169.
32. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM,((1985)) Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 254:: 3187--3189.
33. Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM,((1986)) Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med 314:: 1393.
34. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM,((2006)) Reduced tetanus antibody titers in overweight children. Autoimmunity 39:: 137--141.
35. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, et al.((2011)) Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond). Oct 25.
36. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al.((2010)) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:: 937--948.
37. Travers ME, McCarthy MI,((2011)) Type 2 diabetes and obesity: genomics and the clinic. Hum Genet 130(1):: 41--58.
38. Whigham LD, Israel BA, Atkinson RL,((2006)) Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 290:: R190--R194.
39. Mitra AK, Clarke K,((2010)) Viral obesity: fact or fiction? Obes Rev 11(4):: 289--296.
40. Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, et al.((2011)) Adenovirus-36 Seropositivity Enhances Effects of Nutritional Intervention on Obesity, Bright Liver, and Insulin Resistance. Dig Dis Sci Sep 28.
41. Rössner SM, Neovius M, Montgomery SM, Marcus C, Norgren S,((2008)) Alternative methods of insulin sensitivity assessment in obese children and adolescents. Diabetes Care 31(4):: 802--804.